Evaluation of Safety and Efficacy of TriPollar Device for Treatment of Wrinkles

NCT01858415 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2013-08-13

No results posted yet for this study

Summary

The TriPollar is intended for non invasive treatment of facial wrinkles and rhytides. This study was designed in order to evaluate the safety and efficacy of the TriPollar.

Conditions

  • Facial Wrinkles

Interventions

DEVICE

TriPollar

Sponsors & Collaborators

  • Pollogen

    lead INDUSTRY

Principal Investigators

  • Mira Barki, PhD · Pollogen

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
35 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2013-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01858415 on ClinicalTrials.gov